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Lafoensia pacari A. St.-Hil. can be found from Amapá to Rio Grande do Sul states, and also in Paraguay 
and Bolivia. It is popularly known as pacari or mangava-brava and is used to promote weight loss, as 
an anti-thermal or tonic, to treat gastritis, ulcers, scarring, itching, discouragement, and cancer. In the 
open field tests, the hydroalcoholic extract from L. pacari stem bark (HEP) decreased the number of 
rearings, number of invaded squares, and increased immobility time compared to control animals. In 
the pentobarbital-induced sleep time test, HEP decreased latency time to sleep and increased sleeping 
time. In the rota-rod test, no changes in the studied parameters were observed. In the elevated plus maze, 
HEP increased the percentage time and percentage entries in the open arms, indicating that this extract 
exerts an anxiolytic-like activity.
Uniterms: Lafoensia pacari A. St.-Hil./pharmacognosy. Hydroalcoholic extract. Central Nervous System/
experimental study. Anxiety/experimental study.
Lafoensia pacari A. St.-Hil., uma espécie vegetal presente no Brasil, do Amapá ao Rio Grande do Sul, 
no Paraguai e na Bolívia, é popularmente conhecida como pacari ou mangava-brava e é utilizada como 
emagrecedor, cicatrizante, antitérmico, tônico e para tratar gastrite, úlcera, coceira, desânimo e câncer. 
No teste do campo aberto, o tratamento com o extrato hidro-alcoólico de pacari (HEP) reduziu o número 
de rearings e o número de quadrados invadidos além de aumentar o tempo de imobilidade dos animais 
em relação ao controle. No sono induzido por pentobarbital sódico o tratamento com HEP causou 
redução na latência e aumento na duração do sono. No rota-rod, o tratamento com HEP não alterou os 
parâmetros observados. No teste de labirinto em cruz elevado, com o tratamento com HEP foi observado 
aumento do percentual do tempo de permanência e de entradas nos braços abertos, caracterizando uma 
atividade tipo ansiolítica.
Unitermos: Lafoensia pacari A. St.-Hil/farmacognosia. Extrato etanólico. Sistema Nervoso Central/
estudo experimental. Ansiedade/estudo experimental.
INTRODUCTION
Some time ago the World Health Organization 
(WHO) reported that about 80% of the population in de-
veloping countries used some kind of traditional medicine 
in primary health care, emphasizing the use of herbal pro-
ducts (Farnsworth et al., 1985). According to Farnsworth 
et al. (1985), up until 1985, of the 119 chemicals extracted 
from plants and used in medicine, 74% were first discove-
red through popular knowledge. Koehn & Carter (2005) 
reported that around 25% of prescribed drugs worldwide 
were obtained directly or indirectly from plants. Moreover, 
about 50% of drugs developed between 1981 and 2002 
were obtained from natural products, semi-synthetic ana-
logues or synthetic compounds based on natural products 
(Koehn, Carter, 2005).
In this context, Brazil is well endowed because it 
ranks top among the 17 richest countries in biodiversity 
in the world, possessing approximately 20% of total spe-
cies on the planet (Rates, 2001). The abundance of plant 
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specimens, animals and microorganisms in the Brazilian 
ecosystem, undoubtedly represents an important differen-
tiator in drug development (Kato, 2001).
In the state of Goiás, the medicinal plants are often 
used as an alternative therapy. Among the plants used is 
Lafoensia pacari A. St.-Hil., known popularly as “pacari” 
or “mangava-brava”. L. pacari is a shrub-like plant from 
the Lythraceae family that grows in the Brazilian Savan-
nah, gallery forest, dry forest and altitude forest ecosys-
tems. It is also found from Amapá to Rio Grande do Sul 
states, and also in Paraguay and Bolivia (Santos, 2006).
In folk medicine, the leaves and stem bark are used in 
decoction or macerated (in white wine) forms for healing to 
treat gastric disturbances such as gastritis and ulcers (Pott, 
Pott, 1994; Vieira et al., 2000; Silva, 1998). Other popular 
uses include for treating wounds, itching, discouragement, 
as well as slimming (Tonello, 1997), and as an antipyretic 
or tonic (Mundo, Duarte, 2007). In Paraguay, the stem bark 
is used as a decoction to treat cancer (Solon et al., 2000).
Several studies have demonstrated the antimicrobial 
activity of L. pacari stem bark and leaf extracts (Lima et 
al., 2006; Alves et al., 2000), antiviral activity against 
Herpes simplex virus type 1 (Müller et al., 2007), anti-
inflammatory, analgesic and anti-edematous activities 
(Rogério et al., 2003, 2006, 2007; Matos et al., 2008), anti-
oxidant and anticancer activity of the stem bark (Solon et 
al., 2000), anti-secretory gastric activity by inhibition of 
H+K+-ATPase pump (Murakami et al., 1991), as well as 
potential for using this plant specimen in the treatment 
of dyspepsia (Menezes et al., 2006). Matos et al. (2008) 
demonstrated the sedative effect of aqueous extract from 
stem bark of this plant.
Phytochemical studies on alcoholic extracts from L. 
pacari resulted in the isolation and identification of gallic 
and ellagic acids, with the latter compound being considered 
the major factor responsible for the anti-oxidant and antican-
cer (Solon et al., 2000), anti-secretory gastric (Murakami et 
al., 1991), anti-inflammatory and anti-edematous (Rogério 
et al., 2006) activities of this vegetal specimen.
The aim of this study was to evaluate the pharmaco-
logical activity of ethanol extract from L. pacari stem bark 
on the central nervous system (CNS), in order to enhance 
and characterize the depressant effect observed in the 
aqueous extract, as an anxiolytic-like action.
MATERIAL AND METHODS
Plant Material
The stem bark of Lafoensia pacari was collected 
from the plants in their natural habitat of the savannah 
region of Bela Vista – Goiás state, Brazil (837 m, 16º 58’ 
54.2” S/40º 55’45.1” W) in October 2005 during their 
fructification. The plant material was authenticated by 
Prof. Dr. José Realino de Paula, a Pharmacognosy teacher 
at the Pharmacy Faculty of the Federal University of Goiás 
(UFG) and a voucher specimen was deposited at the Her-
barium of the UFG under number UFG-27031.
Preparation of Hydroalcoholic Extract from L. 
pacari (HEP)
L. pacari stem bark was ground in a Wiley Model 
knife mill. The hydroalcoholic extract from L. pacari 
(HEP) was obtained by maceration in 70% hydro-alco-
holic solution at the proportion of 5%, under agitation for 
72 hours, followed by filtration and concentration under 
vacuum at 60ºC. The extraction yielded 16.1%, compared 
to the powder. At the time of use, the solvent was evapo-
rated and HEP was dissolved in saline (0.9%).
Animals
The animals used in this study were male Swiss al-
bino mice, weighing approximately 30 g from the Central 
Animal House of the UFG. The animals were kept in a 
room with controlled temperature (25 ± 1ºC) and lighting 
(light/dark cycle of 12 h) and food and water ad libitum. 
Animals were kept in the laboratory for an adaptation pe-
riod of at least one hour before the experiments were run, 
with tests usually conducted from 9:00 a.m. to 3:00 p.m. 
All experimental protocols were developed in accordance 
with the principles of ethics and animal welfare recom-
mended by the Brazilian College of Animal Experiments – 
COBEA (2006) and this study was approved by the Ethics 
Commission of the UFG (nº -104/08).
Pharmacological Methods
Effects on Gross Behavior
Experimental groups of mice (n = 5 per group) 
were treated orally (p.o.), intraperitoneally (i.p.) or sub-
cutaneously (s.c.) with HEP at doses of 10, 30, 100, 300 
and 1000 mg/kg, whereas control groups received vehicle 
(saline 10 mL/kg) by the same routes. The animals were 
observed in free ambulation on a flat surface for 3 minutes, 
at 5, 10, 20, 30 and 60 minutes, 4, 8, 24 and 48 hours after 
the treatments and again after 4 and 7 days of treatment. 
The observed effects were noted using a standard pharma-
cological screening approach, adapted from that described 
by Malone (1977). This methodology provided the optimal 
route and dose for the other “in vivo” biological tests.
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Open-Field Test
This test was based on the methodology described by 
Siegel (1946) and validated by Archer (1973), and allowed 
assessment of stimulant or depressant activity. We used 
groups of 9 mice pre-treated (p.o.) with vehicle, HEP (100, 
300, or 1000 mg/kg) or diazepam (1 or 5 mg/kg – used 
as positive control). Sixty minutes after the treatment, the 
animals were placed in the center of an open-field arena 
made of acrylic, with the bottom divided into nine squares 
of equal area. Animals were observed for 5 minutes and 
their exploratory activity (number of squares crossed), 
number of rearings, grooming and fecal bolus were coun-
ted while immobility time was also recorded.
Rota-Rod Test 
The rota-rod test is used to assess if the treatment 
promotes motor incoordination by sedation and/or muscle 
relaxation (Dunham, Miya, 1957). In this test, the animals 
were pre-selected in a training session 24 hours before the 
test based on their permanence on the bar (at 12 rpm) for 2 
minutes. Groups of the pre-selected animals (n = 9) were 
treated (p.o.) with vehicle (saline 10 mL/kg), HEP (100, 
300, or 1000 mg/kg) or diazepam (1 or 5 mg/kg – used as 
positive control) and after 60 minutes the animals were 
placed on the bar, to evaluate the number of falls and the 
time of permanence, where the maximum time allowed 
was 1 minute and the maximum number of falls allowed 
was three.
Pentobarbital-Induced Sleep Time
We used groups of 9 mice pre-treated (p.o.) with 
vehicle (saline 10 mL/kg), HEP (100, 300, or 1000 mg/kg) 
or diazepam (1 or 5 mg/kg). Sixty minutes after the treat-
ment, the animals received sodium pentobarbital 50 mg/
kg i.p., and the time elapsed between the administration 
of pentobarbital until the loss of the righting reflex was 
recorded as the sleep latency, and the time elapsed between 
the loss and voluntary recovery of the righting reflex was 
recorded as total sleeping time (Carlini, Burgos, 1979).
Elevated Plus Maze Test
We used groups of 9 mice pre-treated (p.o.) with 
vehicle (saline 10 mL/kg), HEP (100, 300, or 1000 mg/kg) 
or diazepam (1 mg/kg – used as positive control). Sixty 
minutes after the treatment the animals were individually 
placed at the center of the plus maze (Maze for mice in 
acrylic - EP 150, purchased from Insight Scientific Equi-
pment) with their nose facing the direction of one of the 
closed arms, and observed for 5 minutes (Lister, 1987; 
Pellow et al., 1985). The test occurred under a red light 
and was fully recorded for later analysis, which consisted 
of counting the number of entries into open and closed 
arms, and the time spent by the animal in the open (OAT), 
and closed (CAT) arms. Time spent in open arms was 
later converted into a percentage (% OAT = [(OATx100)/
(OAT+CAT)]). The total number of entries in open and 
closed arms was used as a measure of locomotor activity 
and the percentage of time and number of entries into open 
arms were used as a measure of anxiety.
Statistical Analysis
Results were expressed as means ± standard error of 
mean (SEM) or median with confidence limit. Statistical 
differences between experimental groups were detected 
by analysis of variance (ANOVA) followed by Tukey’s 
test. For models without normal distribution, analysis was 
performed using Kruskal-Wallis’s test followed by Dunn’s 
test. Effects were considered significant at P < 0.05. 
RESULTS
Effects on gross behavior
Animals treated with HEP intraperitoneally (i.p.) 
decreased their spontaneous ambulation, showed anal-
gesia (assessed through the pain reaction caused by the 
compression of distal portion of the tail) and sedation, 
and two deaths occurred by this route at the dose of 1000 
mg/kg (within 8 hours of the treatment) and one at dose 
of 300 mg/kg (within 24 hours of the treatment). Animals 
treated with HEP subcutaneously (s.c.) decreased their 
spontaneous ambulation and showed analgesia, but one 
death occurred at the dose of 1000mg/kg (within 48 hours 
of the treatment). Among the doses tested orally (p.o.) only 
300 and 1000 mg/kg decreased the animals’ spontaneous 
ambulation movements and showed analgesia and no de-
aths occurred by this route where the lower dose did not 
change the assessed parameters.
Open-Field Test
HEP (1000 mg/kg) decreased the total number of 
squares crossed by 41%, compared with control group, 
and also increased the immobility time. The other doses 
did not alter these parameters. Number of fecal bolus was 
reduced by all three doses of HEP (100, 300 and 1000 mg/
kg). The doses of 300 and 1000 mg/kg decreased rearing, 
whereas grooming was not altered by the treatment. Ani-
mals treated with diazepam at a dose of 1 mg/kg showed 
an increase in squares crossed and a decrease in fecal bolus 
whereas at a dose of 5 mg/kg showed a decrease in the 
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squares crossed, rearing and fecal bolus, and an increase 
in immobility time (Table I).
Rota-Rod test
None of the HEP doses altered the number of falls or 
time of permanence of the animal on the rota-rod test (Ta-
ble II), whereas diazepam (5 mg/kg) increased the number 
of falls and decreased the time of permanence on this test.
Pentobarbital-induced sleep time
Treatments with HEP at doses of 300 or 1000 mg/
kg significantly decreased sleep latency from 180.5 ± 
8.1 seconds (control) to 152.9 ± 4.3 and 144.4 ± 5.7 
seconds, respectively (Figure 1), and significantly incre-
ased sleeping time from 82.2 ± 8.01 minutes (control) to 
154.88 ± 11.2 and 223.22 ± 22.8 minutes, respectively 
(Figure 2). The sleep latency and sleeping time were 
not affected by the treatment with HEP 100 mg/kg. 
Animals treated with diazepam (1 or 5 mg/kg), used as 
positive controls in the test, decreased sleep latency and 
increased sleeping time.
Elevated Plus Maze test
Treatment with HEP at doses of 100, 300 and 1000 
mg/kg did not alter the total entries in the open and closed 
arms, but the percentage of entries into the open arms as 
well as the percentage of permanence time in open arms 
were increased by the treatments with HEP at doses of 300 
and 1000 mg/kg, and with diazepam (Table III).
DISCUSSION
Central depressant effects of medicinal plants can 
provide therapeutic benefits in the treatment of anxiety di-
sorders, which represent a significant social cost as a result 
of individual suffering, and indirect social costs including 
reduced productivity (Stein, Seedat, 2004). Among the 
undesirable effects of drugs used as tranquilizers include 
impairment of motor activity, reduction in conditioned refle-
xes, decreased alertness and also sedation, thereby justifying 
the constant search for new drugs with fewer side effects.
Effects on gross behavior caused by treatment with 
HEP are suggestive of central depressant drugs, such as 
decreased spontaneous ambulation and presence of anal-
TABLE I - Effects of hydroalcoholic extract from Lafoensia pacari (HEP) on the open field test, 60 minutes after treatments 
Experimental group Squares crossed Rearings Groomings Fecal bolus Immobility time (s)
Control 62.60 ± 3.80 41.17 ± 3.00 4.00 ± 0.87 5.57 ± 0.84 7.42 ± 3.20
HEP 100 mg/kg 58.33 ± 4.11 34.14 ± 6.15 4.50 ± 0.60 2.00 ± 0.27** 6.00 ± 1.77
HEP 300 mg/kg 49.00 ± 3.15 21.83 ± 4.50* 5.42 ± 0.84 1.86 ± 0.67** 29.25 ± 4.21
HEP 1000 mg/kg 37.88 ± 4.39* 18.83 ± 2.49** 6.00 ± 1.17 1.80 ± 0.58*** 51.40 ± 4.90**
DZP 1 mg/kg 87.4 ± 6.10* 52.45 ± 4.9 5.79 ± 2.10 2.7 ± 0.68 * 3.1 ± 1.8
DZP 5 mg/kg 30.20 ± 8.66** 7.17 ± 2.50*** 2.33 ± 1.17 1.00 ± 0.63*** 83.20 ± 17.65***
Data expressed as mean ± SEM of nine mice. Control: vehicle (saline, 10 mL/kg, p.o.), HEP: Hydroalcoholic extract from Lafoensia 
pacari stem bark (p.o.), DZP: Diazepam (p.o., positive control). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 compared with control group.
TABLE II - Effects of hydroalcoholic extract from Lafoensia pacari (HEP) on the rota-rod test, 60 minutes after treatments
Experimental group Numbers of falls Time of permanence (s) 
Median Confidence limit Median Confidence limit
Control 0 0 – 0.3 60 60 – 60
HEP 100 mg/kg 0 0 – 0.7 60 60 – 60
HEP 300 mg/kg 0 0 – 0.8 60 60 – 60
HEP 1000 mg/kg 1 0 – 1.3 60 60 – 60
DZP 1 mg/kg 1 0.4 – 1.5 58 51 – 59
DZP 5 mg/kg 3*** 2.3 – 3 40*** 37 – 48
Data expressed as median and confidence limits of nine mice. Control: vehicle (saline, 10 mL/kg, p.o.), HEP: Hydroalcoholic 
extract from Lafoensia pacari stem bark (p.o.), DZP: Diazepam (p.o., positive control). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
compared with control group.
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FIGURE 1 - Effect of hydroalcoholic extract from Lafoensia pacari on sleep latency (s) in pentobarbital-induced sleep time test 
in mice (n = 9) pre-treated (60 min, p.o.) with vehicle (saline, 10 mL/kg), hydroalcoholic extract from Lafoensia pacari stem bark 
(HEP, 100, 300 or 1000 mg/kg) or diazepam (DZP, 1 or 5 mg/kg). The columns and vertical bars express means ± SEM. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.001 compared with control group.
FIGURE 2 - Effect of hydroalcoholic extract from Lafoensia pacari on sleeping time (min) in pentobarbital-induced sleep time 
test in mice (n = 9) pre-treated (60 min, p.o.) with vehicle (saline, 10 mL/kg), hydroalcoholic extract from Lafoensia pacari stem 
bark (HEP, 100, 300 or 1000 mg/kg) or diazepam (DZP, 1 or 5 mg/kg). The columns and vertical bars express means ± SEM. 
** p ≤ 0.01, *** p ≤ 0.001 compared with control group.
TABLE III – Effects of hydroalcoholic extract from Lafoensia pacari (HEP) on elevated plus maze test, 60 minutes after treatments
Experimental group Total entries in open and 
closed arms
Percentage of entries in open 
arms
Percentage of time in open 
arms
Control 23.00 ± 1.25 37.49 ± 3.69 40.37 ± 6.16
HEP 100 mg/kg 23.78 ± 1.89 36.80 ± 3.90 41.93 ± 6.27
HEP 300 mg/kg 26.55 ± 1.77 54.14 ± 2.46* 61.88 ± 3.61*
HEP 1000 mg/kg 26.22 ± 1.77 52.37 ± 2.79* 60.78 ± 3.21*
DZP 1 mg/kg 24.11 ± 1.60 74.55 ± 4.16 *** 72.35 ± 4.94***
Data expressed as mean ± SEM of nine mice. Control: vehicle (saline, 10 mL/kg, p.o.), HEP: Hydroalcoholic extract from Lafoensia 
pacari stem bark (p.o.), DZP: Diazepam (p.o., positive control). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 compared with control group.
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gesia. Considering the absence of deaths throughout the 
period of observation in the group of mice treated orally, 
this route is most promising for further evaluations. We 
observed changes in animals’ behavior only from doses of 
300 mg/kg and greater, and therefore the doses of 100, 300 
and 1000 mg/kg were selected for further tests to verify a 
dose-response relationship over this range.
Despite the deaths following the administration of 
higher doses of crude extract through the intraperitoneal 
and subcutaneous routes, these plant extracts are not con-
sidered toxic in acute oral treatment. This was evidenced 
by Lago (2004) who showed that the LD50 in rats was not 
achieved even at the dose of 5.0 g/kg, and by Menezes 
et al. (2006) who used a dose of 1.0 g/kg daily in human 
volunteers in a study on the therapeutic use of Lafoensia 
pacari extract in Helicobacter pylori eradication. The 
deaths caused by intraperitoneal and subcutaneous routes 
may have been due to the presence of saponins in its cons-
titution (Galdino et al., 2009), since most of the molecules 
of this class of secondary metabolites have hemolytic 
activity (Schenkel et al., 2004).
Five parameters were evaluated in the open field 
test: total number of squares crossed (assessing animal 
exploratory activity and may be affected by CNS-acting 
drugs or peripheral muscle relaxants), number of rearings 
and grooming, and immobility time (assessing degree of 
sedation or fear (anxiety) and may be altered by anxiolytic 
and anxiogenic drugs), and lastly, number of fecal bolus 
that can be altered by spasmolytics and spasmogenic drugs 
or drugs that alter animal emotionality, whereas this pa-
rameter can also be reduced by anxiolytic drugs (Archer, 
1973; Siegel, 1946).
HEP decreased fecal bolus from doses of 100 mg/
kg and greater, decreased number of rearings from 300 
mg/kg, and at the dose of 1000 mg/kg decreased squares 
crossed while increasing immobility time, although groo-
ming remained altered. Similar effects were observed after 
treatment with diazepam 5 mg/kg. These results suggest a 
CNS depressant activity or motor incoordination.
To verify if the data obtained in the open field test 
were due to animal motor incoordination caused by the 
extract we used the rota-rod test, a classic test to evaluate 
motor coordination, where an increase in number of falls 
or decrease in permanence time indicates motor incoor-
dination (Dunham, Myla, 1957). Neither the number of 
falls or the permanence time were altered by the treatment 
with HEP, suggesting that the reduction in the number of 
squares crossed and the increase in immobility time were 
not due to motor incoordination, but possibly due to central 
depressant activity.
Continuing with investigation of the central depres-
sant activity initially observed in the open field test, we as-
sessed HEP effects on pentobarbital-induced sleep time. In 
this test, substances that are CNS depressant typically incre-
ase sleeping time produced by pentobarbital, and may also 
decrease sleep latency (Carlini, Burgos, 1979). Agonists of 
binding sites located on GABA receptor type A (Chweh et 
al., 1987; Lancel, 1999), such as benzodiazepines, exhibit 
these effects, evidenced primarily by prolonging the slee-
ping time. The treatments with diazepam or HEP at doses of 
300 and 1000 mg/kg, produced a reduction in sleep latency 
and an increase in sleeping time, reinforcing the depressant 
activity attributed to the crude extract. However, some fac-
tors that interfere with barbiturate metabolism can result 
in false positives using this methodology (Carlini, Burgos, 
1979), a phenomenon that does not seem to occur with HEP, 
because the treatment with the extract increased sleeping 
time and reduced sleep latency, where this reduction does 
not occur in false positive results in this model.
This CNS depressant activity may be due to an 
anxiolytic-like activity of the extract and to assay this 
activity the elevated plus maze test was used, perhaps the 
most widely employed anxiety animal model. Animals’ 
(rats or mice) natural behavior is to display aversion to 
open spaces, represented by avoidance of the open arms. 
The elevated plus maze test tries to simplify and mimic the 
animal “anxiety-state” which arises in an intensified form 
in stressful or anxiogenic conditions (Belzung, Griebel, 
2001; Bertoglio, Carobrez, 2005).
The effectiveness of the anxiolytic drug in the eleva-
ted plus maze test is illustrated by a significant increase in 
exploratory parameters for open arms (percentage of time 
and entries into open arms), while the opposite is true for 
anxiogenic drugs, without changes in motor activity, repre-
sented by total entries into open and closed arms (Lister, 
1987; Vasconcelos et al., 2004; Bertoglio, Carobrez, 2005; 
Rodgers, Cole, 1994).
Treatment with the extract at doses of 300 and 1000 
mg/kg increased the exploratory parameters on open arms 
without changes in motor activity, results similar to those 
obtained in animal treated with diazepam at a dose of 1mg/
kg. Therefore, the results obtained in the present study 
using the hydroalcoholic extract from Lafoensia pacari 
A. St.-Hil. stem bark suggest an anxiolytic-like activity.
CONCLUSION
The results of this study allow us to conclude that 
hydroalcoholic extract of Lafoensia pacari A. St.-Hil. 
stem bark produced acute CNS depression without alte-
ring motor coordination of the animals. This depressant 
action involves an anxiolytic-like activity at doses that 
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do not impair motor activity. Through purification of the 
crude extract and identification of active compounds the 
mechanisms of action can be characterized.
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